Comments
FDA OKs J&J prostate cancer drug for pre-chemo use
11.12.2012. | (Reuters) - U.S. health regulators on Monday expanded the approval of Johnson & Johnson's drug Zytiga for advanced prostate cancer to allow its use prior to treatment with chemotherapy....
